StonvexLoading…
StonvexStonvexStonvexCore line items from SUNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.31M | $21.57M | $16.35M | $10.29M |
Operating Income | $4.25M | $12.14M | $10.51M | $6.46M |
Net Income | $4.25M | $12.14M | $10.51M | $6.46M |
EPS (Diluted) | $0.32 | $0.93 | $0.82 | $0.52 |
Total Assets | $330.03M | $310.23M | $258.83M | $256.49M |
Total Liabilities | $147.50M | $128.27M | $74.22M | $72.17M |
Cash & Equivalents | $5.66M | $6.45M | $5.55M | $5.57M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 13.52M | 13.42M | 13.42M | 13.42M |